Arvind
Ravichandran

Mr. Ravichandran’s notable matters include representing:

• FS Investments in its combination with Portfolio Advisors, creating a $75 billion alternative investment firm;
• Occidental in its $57 billion acquisition of Anadarko;

• Shire in its $32 billion combination with Baxalta;

• Novartis in the $29.8 billion spin‑off of Alcon;

• Pinnacle Foods in its $10.9 billion acquisition by Conagra and its $975 million acquisition of Boulder Brands;

• Northrop Grumman in the $3.4 billion sale of its federal IT and mission support business to Veritas Capital;

• BDT and its affiliates in connection with BDT’s combination with MSD Partners, the take‑private acquisition of Weber, valuing Weber at $3.7 billion, and various private investments in excess of $3 billion;

• Roivant Sciences in its $3 billion Strategic Alliance with Sumitomo Dainippon Pharma;

• The special committee of the board of Eidos Therapeutics in the $2.83 billion merger with BridgeBio Pharma;

• IBM in multiple transactions, including its $2.6 billion acquisition of Truven Health Analytics, its acquisition of Resilient Systems and its acquisition of the product and technology businesses of The Weather Company;

• GreenSky in its $2.24 billion acquisition by Goldman Sachs;

• Swvl in its $1.5 billion SPAC combination with Queen’s Gambit, including a $111.5 million PIPE investment and a $471.7 million equity financing facility;

• GuideWell in its $900 million combination with Triple‑S Management;

• Lazard in its $575 million SPAC IPO;

• Eurazeo North America, as manager of funds affiliated with Eurazeo SE, in its capacity as controlling shareholder of WorldStrides and lender under the $368 million DIP facility in the pre‑packaged Chapter 11 proceedings of WorldStrides;

• Aramex in its $265 million acquisition of MyUS;
• Aras in its substantial growth investment from GI Partners;

• Barrick Gold in its joint venture with Newmont;
• Hayfin in the pending sale of Autovista to J.D. Power;
• Owl Rock in its investment in Amergin Asset Management and Fifth Season Investments’ $220 million acquisition of Fifth Season Financial and the life insurance investment assets of Chapford Capital II and Chapford Diversified Strategies Fund;

• PG&E in various matters related to its bankruptcy and emergence, including its tri‑tranche offering, which represents the largest utility public equity offering in history;

• Proximo Spirits in its acquisition of the remaining stake in EBS, which owns Conor McGregor’s Proper No. Twelve Irish Whiskey brand;

• Unilever in the unification of its dual‑headed legal structure under a single parent company; and

• Xerox in its spin‑off of Conduent.

Mr. Ravichandran was named a “Rising Star” by Law360 in 2023, recognizing him as one of four outstanding tax lawyers in the nation under the age of 40, and has been named to the Lawdragon 500 X – The Next Generation list. He has been recognized for his work in the tax arena by The Legal 500 US. Mr. Ravichandran is a member of the Executive Committee of the Tax Section of the New York State Bar Association and was selected to serve on Law360’s Tax Authority International Editorial Advisory Board.

Mr. Ravichandran was born in State College, Pennsylvania. He received a B.A. from Columbia University in 2009 and a J.D. from Columbia Law School in 2012, where he was a James Kent Scholar and a Harlan Fiske Stone Scholar.

Mr. Ravichandran joined Cravath in 2015 and was elected a partner in 2021. Prior to joining Cravath, he worked as an attorney in the Internal Revenue Service Office of Chief Counsel.